Tim Lugo's Stock Ratings

William Blair Analyst

Tim Lugo is an analyst at William Blair. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/30/2025

Overall Average Return

-28.4%

Smart Score

31.3%

Overall Average Return Percentile

8th

Number of Ratings

37
Buy NowGet Alert
11/15/2024EYENBuy Now
Eyenovia
$11.16
Tim Lugo31%
DowngradeOutperform → Market PerformGet Alert
10/30/2024BMRNBuy Now
Biomarin Pharmaceutical
$55.80
Tim Lugo31%
DowngradeOutperform → Market PerformGet Alert
08/12/2024RVNCBuy Now
Revance Therapeutics
Tim Lugo31%
DowngradeOutperform → Market PerformGet Alert
07/31/2024APLTBuy Now
Applied Therapeutics
$0.31
Tim Lugo31%
Initiates → OutperformGet Alert
04/15/2024LENZBuy Now
LENZ Therapeutics
$29.31
Tim Lugo31%
Initiates → OutperformGet Alert
03/28/2024SLDBBuy Now
Solid Biosciences
$4.89718%
Tim Lugo31%
→ $40Initiates → OutperformGet Alert
03/12/2024ZVRABuy Now
Zevra Therapeutics
$8.91
Tim Lugo31%
Initiates → OutperformGet Alert
01/29/2024ABBVBuy Now
AbbVie
$185.35
Tim Lugo31%
UpgradeMarket Perform → OutperformGet Alert
12/18/2023ALLKBuy Now
Allakos
Tim Lugo31%
UpgradeMarket Perform → OutperformGet Alert
11/13/2023ACRSBuy Now
Aclaris Therapeutics
$1.45
Tim Lugo31%
DowngradeOutperform → Market PerformGet Alert
11/01/2023EYENBuy Now
Eyenovia
$11.16
Tim Lugo31%
Initiates → OutperformGet Alert
09/21/2023TVTXBuy Now
Travere Therapeutics
$14.80
Tim Lugo31%
DowngradeOutperform → Market PerformGet Alert
09/20/2023SPRYBuy Now
ARS Pharmaceuticals
$17.11
Tim Lugo31%
DowngradeOutperform → Market PerformGet Alert
07/25/2023ABBVBuy Now
AbbVie
$185.35
Tim Lugo31%
Initiates → Market PerformGet Alert
01/04/2023SPRYBuy Now
ARS Pharmaceuticals
$17.11
Tim Lugo31%
Initiates → OutperformGet Alert
07/22/2022VTGNBuy Now
VistaGen Therapeutics
$2.10
Tim Lugo31%
DowngradeOutperform → Market PerformGet Alert
03/08/2022BBIBuy Now
Brickell Biotech
Tim Lugo31%
Initiates → OutperformGet Alert
12/22/2021ALLKBuy Now
Allakos
Tim Lugo31%
DowngradeOutperform → Market PerformGet Alert
11/22/2021BMRNBuy Now
Biomarin Pharmaceutical
$55.80
Tim Lugo31%
UpgradeMarket Perform → OutperformGet Alert
10/11/2021ADMSBuy Now
Adamas Pharmaceuticals
Tim Lugo31%
DowngradeOutperform → Market PerformGet Alert
07/13/2021KNTEBuy Now
Kinnate Biopharma
Tim Lugo31%
Initiates → OutperformGet Alert
06/16/2021SAGEBuy Now
Sage Therapeutics
$9.12579.82%
Tim Lugo31%
→ $62DowngradeOutperform → Market PerformGet Alert
01/04/2021VTGNBuy Now
VistaGen Therapeutics
$2.10
Tim Lugo31%
UpgradeMarket Perform → OutperformGet Alert
11/24/2020AVIRBuy Now
Atea Pharmaceuticals
$3.60
Tim Lugo31%
Initiates → OutperformGet Alert
08/20/2020BMRNBuy Now
Biomarin Pharmaceutical
$55.80
Tim Lugo31%
DowngradeOutperform → Market PerformGet Alert
01/08/2020XENEBuy Now
Xenon Pharmaceuticals
$31.30
Tim Lugo31%
Initiates → OutperformGet Alert
08/28/2019VTGNBuy Now
VistaGen Therapeutics
$2.10
Tim Lugo31%
Initiates → OutperformGet Alert
08/13/2018ALLKBuy Now
Allakos
Tim Lugo31%
Initiates → OutperformGet Alert
09/22/2017AKTXBuy Now
Akari Therapeutics
$1.16
Tim Lugo31%
UpgradeMarket Perform → OutperformGet Alert
05/30/2017BHVNBuy Now
Biohaven
$14.16224.86%
Tim Lugo31%
→ $46Initiates → OutperformGet Alert
05/30/2017OVIDBuy Now
Ovid Therapeutics
$0.32
Tim Lugo31%
Initiates → OutperformGet Alert
05/12/2017AKTXBuy Now
Akari Therapeutics
$1.16
Tim Lugo31%
DowngradeOutperform → Market PerformGet Alert
04/25/2017AKRXBuy Now
Akorn
Tim Lugo31%
DowngradeOutperform → Market PerformGet Alert
04/06/2017RTRXBuy Now
Retrophin
Tim Lugo31%
Initiates → OutperformGet Alert
03/23/2016AKRXBuy Now
Akorn
Tim Lugo31%
$58 → $36MaintainsOutperformGet Alert
05/05/2014ADMSBuy Now
Adamas Pharmaceuticals
Tim Lugo31%
→ $35Initiates → OutperformGet Alert
09/12/2012BMRNBuy Now
Biomarin Pharmaceutical
$55.80
Tim Lugo31%
Get Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free